Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova's VNS Therapy for Drug-Resistant EpilepsyBusiness Wire · 1 day ago
LivaNova PLC $LIVN Shares Newly Acquired by Avidian Wealth Enterprises LLCDefense World · Oct 11, 2026
Squarepoint Ops LLC Acquires Shares of 17,242 LivaNova PLC $LIVNDefense World · Sep 17, 2026
LivaNova PLC (LIVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha · Sep 14, 2026
LivaNova Director Sells 1,650 Shares for $131,500The Motley Fool · Sep 10, 2026
LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DEDefense World · Aug 15, 2026LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | $1.09 | $1.26 | Beat |
| May 6, 2026 | $0.85 | $0.98 | Beat |
| Feb 25, 2026 | $0.80 | $0.86 | Beat |
| Nov 5, 2025 | $0.92 | $1.11 | Beat |
| Aug 6, 2025 | $0.84 | $1.05 | Beat |
| May 7, 2025 | $0.75 | $0.88 | Beat |